Token-based certifications for consumer health products

Token-based certifications for consumer health products


Raised this Round: Raised: $11,872

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type


SEC Filing Type

RegCF    Open SEC Filing

Year Founded



Healthcare & Pharmaceuticals

Tech Sector


San Francisco, California

TEST is the first token-based certification program for consumer health products. They were built by affiliate Labdoor, Y Combinator W15 batch alumni. Labdoor has raised $7M, and was cited by John Oliver, the NYT, and the Today Show. Plus, they’ve tested over 1,000 products to help millions of people research, find, and buy supplements. TEST is the vehicle to bring a tokenized version of Labdoor to the market by incentivizing companies to publicly test the quality of their products. TEST holders can challenge other applicants, and product challenges can be won or lost based on scientific testing performed by a TEST-registered laboratory.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
TEST on Republic
Platform: Republic
Security Type: Debt

Follow company

Follow TEST on Republic

Buy TEST's Deal Report

Warning: according to the close date for this deal, TEST may no longer be accepting investments.

TEST Deal Report

Get KingsCrowd’s comprehensive report on TEST including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether TEST is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the TEST deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge